Desmopressin

Generic Name
Desmopressin
Brand Names
Ddavp, Nocdurna, Octostim
Drug Type
Small Molecule
Chemical Formula
C46H64N14O12S2
CAS Number
16679-58-6
Unique Ingredient Identifier
ENR1LLB0FP
Background

Desmopressin (dDAVP), a synthetic analogue of 8-arginine vasopressin (ADH), is an antidiuretic peptide drug modified by deamination of 1-cysteine and substitution of 8-L-arginine by 8-D-arginine. ADH is an endogenous pituitary hormone that has a crucial role in the control of the water content in the body. Upon release from the stimulation of increased plasm...

Indication

1.治疗中枢性尿崩症,可减少尿量、提高尿渗透压、降低血浆渗透压;

2.用于尿崩症的诊断和鉴别诊断;

3.用于治疗夜间遗尿症(六岁或以上的患者);

4.部分类型(甲型血友病和Ⅰ型血管性假血友病)的血友病及其他出血性疾病。

Associated Conditions
Bleeding, Hypothalamic Injury-induced Obesity (HIO), Nocturia, Nocturnal Polyuria, Polydipsia, Polyuria, Primary Nocturnal Enuresis
Associated Therapies
-

Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study

Phase 4
Completed
Conditions
Interventions
First Posted Date
2011-09-23
Last Posted Date
2022-12-15
Lead Sponsor
University Hospital, Ghent
Target Recruit Count
5
Registration Number
NCT01439997
Locations
🇧🇪

University Hospital Ghent, Ghent, Belgium

Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study

Phase 4
Completed
Conditions
Interventions
First Posted Date
2011-09-15
Last Posted Date
2014-12-05
Lead Sponsor
University Hospital, Ghent
Target Recruit Count
50
Registration Number
NCT01435083
Locations
🇧🇪

University Hospital Ghent, Ghent, Belgium

Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-12-17
Last Posted Date
2015-10-15
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
395
Registration Number
NCT01262456
Locations
🇺🇸

Avail Clinical Research, LLC, DeLand, Florida, United States

🇺🇸

FutureCare Studies, Inc., Springfield, Massachusetts, United States

🇺🇸

Urology Center Research Institute, Englewood, New Jersey, United States

and more 43 locations

Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-10-19
Last Posted Date
2015-10-15
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
268
Registration Number
NCT01223937
Locations
🇺🇸

Medical Affiliated Research Center Inc., Huntsville, Alabama, United States

🇺🇸

Family Medical Center, Foothill Ranch, California, United States

🇺🇸

Front Range Clinical Research, Wheatridge, Colorado, United States

and more 34 locations

Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo

Phase 2
Completed
Conditions
Interventions
First Posted Date
2010-08-19
Last Posted Date
2012-05-25
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
116
Registration Number
NCT01184859
Locations
🇯🇵

National Center for Geriatrics and Gerontology, Obu, Aichi, Japan

🇯🇵

Jyusendo General Hospital, Koriyama, Fukushima, Japan

🇯🇵

Kawahara Hinyoukika, Kagoshima, Japan

and more 33 locations

Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-03-02
Last Posted Date
2011-11-02
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
89
Registration Number
NCT01078753
Locations
🇯🇵

Kansai Medical University Hirakata Hospital, Hirakata, Osaka, Japan

🇯🇵

Tamura Children's Clinic, Mito, Ibaraki, Japan

🇯🇵

Shinbo Child Clinic, Yokohama, Kanagawa, Japan

and more 12 locations

Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS)

First Posted Date
2009-05-15
Last Posted Date
2011-04-19
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
138
Registration Number
NCT00902265
Locations
🇩🇪

Investigational Site - Kurfürstendamm 33, Berlin, Germany

🇩🇪

Investigational Site - Marburger Straße 12/13, Berlin, Germany

🇩🇪

Investigational Site - Mehrower Allee 22, Berlin, Germany

and more 63 locations

Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity

Phase 4
Completed
Conditions
Interventions
First Posted Date
2009-05-15
Last Posted Date
2009-05-15
Lead Sponsor
Samsung Medical Center
Target Recruit Count
103
Registration Number
NCT00902655
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

🇰🇷

Keimyung University School of Medicine, Daegu, Korea, Republic of

🇰🇷

College of Medicine Inha University, Inchon, Korea, Republic of

and more 3 locations

Desmopressin for Bleeding Related to Low Body Temperature

First Posted Date
2009-05-14
Last Posted Date
2009-05-14
Lead Sponsor
The University of Hong Kong
Target Recruit Count
48
Registration Number
NCT00902057
Locations
🇨🇳

The University of Hong Kong, Hong Kong, Hong Kong, China

Desmopressin as Treatment for Postoperative Bleeding After Cardiac Surgery

First Posted Date
2009-04-22
Last Posted Date
2015-04-08
Lead Sponsor
St. Olavs Hospital
Target Recruit Count
17
Registration Number
NCT00885924
Locations
🇳🇴

StOlavs Hopital, Trondheim, Norway

© Copyright 2024. All Rights Reserved by MedPath